Building Neuroscience Research Infrastructure for Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) in Africa (UG3/UH3 Clinical Trial Not Allowed)

US Dept. of Health & Human Services: National Institutes of Health (NIH)

Next deadline: Jan 12, 2024 (Letter of inquiry)

Later deadlines: Feb 14, 2024 (Full proposal)

Grant amount: Up to US $3,000,000

Funding uses: Research, Training / Capacity Building

Location of project: Africa, United States, American Samoa, Guam, Northern Mariana Islands, Puerto Rico, Virgin Islands Show all

Location of residency: United States, American Samoa, Guam, Northern Mariana Islands, Puerto Rico, Virgin Islands Show all

Overview:

This notice of funding opportunity (NOFO) promotes collaborative research programs to support the development/enhancement of infrastructure (e.g., tools, surveys, biospecimens, data) for Alzheimer's disease (AD) and AD-related dementias (AD/ADRD) neuroscience research in low- and middle-income countries (LMICs) in Africa. Specifically, the National Institute on Aging (NIA) seeks to support Phase Innovation Awards Cooperative Agreement (UG3/UH3) projects to enable: 

• the formation of transformative collaborations between institutions/scientists in the US and LMICs in Africa; 
• the development, or enhancement of research infrastructure and resources for studies of AD/ADRD neuroscience relevant to Africa as well as to examine how social or behavioral factors influence AD/ADRD in Africa;
• the initiation of pilot or exploratory studies that will inform future research for AD/ADRD neuroscience in Africa.

These research infrastructure programs are expected to contribute to the long-term goals of building sustainable AD/ADRD neuroscience research capacity and research, ultimately leading to prevention and mitigation strategies for AD/ADRD in Africa. 

We've imported the main document for this grant to give you an overview. You can learn more about this opportunity by visiting the funder's website.